Dr. Ann Marie Egloff was born in Owosso, Michigan, where she was raised in a family that highly valued education and community service. Her mother, a science teacher, and her father, a school administrator, played pivotal roles in shaping her dedication to learning and civic engagement. She excelled in her academic pursuits at Swartz Creek High School, earning honors in math and science and participating in varsity basketball, track and field, and diving. Alongside her sports involvement, she contributed to student council, theater, and ballet, reflecting her well-rounded interests and leadership skills.

Dr. Egloff continued her education at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. This laid the foundation for her professional path in biomedical research, which began with her role at Warner-Lambert Parke-Davis. She worked on molecular cloning and small-molecule inhibitors, contributing to therapeutic efforts for cancer and metabolic diseases. Her dedication and contributions during this time were recognized through employee awards.

Her growing passion for scientific discovery led her to pursue a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Dr. Egloff’s doctoral research focused on immune cell signaling pathways, shedding light on their importance in the body’s response to various diseases. Following her PhD, she completed a postdoctoral fellowship at the National Human Genome Research Institute, where she worked on cancer-causing gene mutations and earned recognition for her groundbreaking research.

Dr. Egloff furthered her career at the University of Pittsburgh by joining an NIH/NCI-sponsored Cancer Education and Career Development Program. Her research focused on translating laboratory discoveries into clinical applications, particularly in developing personalized cancer treatments. As an Assistant Professor at the University of Pittsburgh School of Medicine, she led innovative research on head and neck cancers and contributed to developing targeted therapies.

In 2015, Dr. Egloff took her expertise to Boston University, where she expanded her role in research and mentorship. She now works at Brigham and Women's Hospital and Harvard Medical School, focusing on tumor immunology and precision medicine in cancer treatment.

Dr. Ann Marie Egloff’s career reflects her unwavering commitment to scientific progress, education, and community service. Her work significantly impacts cancer research, and she remains dedicated to mentoring the next generation of scientists.